Clinical guideline: manual red cell exchange in patients with sickle cell disease

Similar documents
Blood Transfusions in Children with Haemoglobinopathies

Transfusion in Sickle Cell Disease What the guidelines [are likely to] say. Dr Bernard Davis Whittington Hospital, London

Acute painful crisis in patients with sickle cell disease: Clinical Guidelines (HN-506a)

Venesection Nursing Guidelines

Venepuncture and Cannulation. Louise Smith Clinical Nurse Specialist

Chapter 8 ADMINISTRATION OF BLOOD COMPONENTS

SICKLE CELL AWARENESS. The Sickle Cell Society has produced the following information leaflets available at sicklecellsociety.org

Clinical Guidelines on the Use of Iron Chelation in Children Receiving Regular Blood Transfusions

BPG 03: Continuous Renal Replacement Therapy (CRRT)

Aneurin Bevan University Health Board Sickle Cell Anaemia and Haemoglobinopathy Screening and Management in Pregnancy Guidelines

TRANSFUSION OF BLOOD COMPONENTS ADMINISTRATION. All blood components are administered according to BOP DHB Policy and NZBS Guidelines.

Information for patients with Sickle Cell Disease who may need a blood transfusion. Patient information

The use of red cell genotyping in the management of sickle cell disease

IV Fluids. Nursing B23. Objectives. Serum Osmolality

IV Fluids Nursing B23 Objectives Serum Osmolality 275 to 295 Isotonic

Peri-Operative Management: Guidelines for Inpatient Management of Children with Sickle Cell Disease

Hydroxyurea and Transfusion Therapy for the Treatment of Sickle Cell Disease

Guideline for the Management of Acute Chest Syndrome in Children with Sickle Cell Disease

Apheresis Service Annual Haemoglobinopathy Course Sept, 2012

Beaumont Hospital Department of Transplantation, Urology and Nephrology. Guideline for administering Intravenous Ferinject in the Renal Unit

Guidelines on the Management of a Child with Sickle Cell Disease and low Haemoglobin

The Management of Acute Chest Syndrome in Children with Sickle Cell Disease

Dependance on chronic transfusion

Management of Severe Jaundice / Exchange Transfusion

Sickle cell anaemia. GP Education Update 19 th July 2018 Croydon University Hospital. Arne de Kreuk Consultant Haematologist

404FM.2 CONTINUOUS RENAL REPLACEMENT THERAPY (CRRT) USING CITRATE Target Audience: Hospital only ICU. (Based on Gambro and Kalmar Hospital protocols)

PREOPERATIVE ANAEMIA PATHWAY

PREOPERATIVE ANAEMIA PATHWAY

PHASE 2a - INITIAL ASSESSMENT OF CLINICAL SKILLS IN SIMULATION (IACSS)

Erythrocytapheresis vs continuous Manual Exchange Transfusion to treat cerebral macrovasculopathy in children with sickle cell anemia

Guidelines on the Management of a Child with Sickle Cell Disease and low Haemoglobin

Blood is serious business

Hydroxyurea (Hydroxycarbamide) - Guidelines for treating children with Sickle Cell Disease

Drug and Therapeutics committee, Clinical Haematology Directorate. Department of Haematology, Nottingham City Hospital

Joanne Mallon, Nora O Neill, Dr D Hull Antenatal midwife coordinator, Consultant Haematologist

CONTROLLED DOCUMENT. Guidelines for the use of subcutaneous hydration in palliative care (hypodermoclysis) Controlled Document Number: CG259

This guideline describes the care required for a patient receiving a red blood cell transfusion whilst undergoing extra corporeal therapies.

4.0 Definitions. Subcutaneous: is defined as the loose connective tissue between the epidermis and the muscle.

Trust Guideline for the Management and Administration of Intravenous Iron in Adults under the Gastroenterology Directorate

NICE Guidance on Spectra Optia for automated red cell exchange in patients with Sickle Cell Disease

Case Study 1: Red Cell Exchange

Consensus view on choice or iron chelation therapy in transfusional iron overload for inherited anaemias

Guideline for the Acute Management of Stroke in Paediatric Patients with Sickle Cell Disease

Exchange Transfusion

Hydroxyurea (Hydroxycarbamide) - Guidelines for treating children with Sickle Cell Disease

Emergency Presentations of Sickle cell disease. Dr S Pancham Sickle Cell & Thalassaemia Centre City Hospital

Magnesium Sulphate - Management of Hypertensive Disorders of Pregnancy

Thalassaemia and Abnormal Haemoglobins in Pregnancy

Measuring body temperature, blood pressure, pulse, respiratory rate and oxygen saturation

Transfusions in Sickle Cell Disease: How, When and Why

Goal Directed Therapy : Liberal vs Restrictive Transfusion.. Syafri Kamsul Arif

Unit 5: Blood Transfusion

Rationale for RBC Transfusion in SCD

INTRAVENOUS HYDRALAZINE POLICY

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE SCOPE

Standard Operating Procedure for cannulation

Information for Patients

Administration of blood components. Tina Parker - Transfusion Practitioner

Dr Charlie Baker Consultant Anaesthetist UHNM. Being a place our f amilies would choose

Nursing Management Pre /Post Thrombolysis in Stroke

BASINGSTOKE AND NORTH HAMPSHIRE NHS FOUNDATION TRUST. Clinical Policy for Peripheral Venous Cannula Insertion and Management (Adults)

PATIENT CARE PLAN FOR CARE OF PERIPHERAL MIDLINE. Manufacturers specific recommendations should be noted and adhered to by individual practitioners.

Transfusion-Related Acute Lung Injury (TRALI) and Strategies for Prevention. Khalid Abdulla Sharif, MD, MRCP (UK)*

BLOOD CULTURE POLICY FOR PAEDIATRICS

Chapter 6: Blood Transfusion in the Management of Sickle Cell Disease

Fluids and electrolytes: the basics

All institutions that transfuse blood components and products should implement national and local policies and written procedures for:

Dr Banu Kaya Consultant Haematologist Barts Health NHS Trust Royal London Hospital, London, UK SICKLE CELL AND THALASSAEMIA OVERVIEW

Vascular access device selection & placement. Alisa Seangleulur, MD Anesthesiology Department, Faculty of Medicine, Thammasat University

Education for Self Administration of Intravenous Therapy HOME IV THERAPY PICC. Portacath

Policy for the safe handling and administration of cytotoxic drugs for Children, Teenagers and Young Adults with Cancer

Curraheen, Co. Cork. Guidelines on the Management and Care of Central Venous Access Devices

Guidelines for the Immediate Management of Paediatric Patients with Sickle Cell Disease (SCD) and Acute Neurological Symptoms

Transfusion Medicine Potpourri. BUMC - Phoenix Internal Medicine Residents September 29, 2015

Blood & Blood Product Administration

Core procedures assessment form

Course Syllabus National College of Midwifery /2017

THERAPEUTIC PLASMA EXCHANGE

SOUTHERN HEALTH & SOCIAL CARE TRUST. Children & Young People s Directorate Procedure/Guidelines/Protocol Checklist & Version Control Sheet

INFLECTRA Infliximab Infusion 1,2 & 3

Alister Jones Patient Blood Management Practitioner NHS Blood and Transplant

Less than 50kgs protocol

Education for self administration of intravenous therapy HOME IV THERAPY. 30 minute - Baxter Pump Tobramycin

Contents of the standard response bag used for Faculty of Pre-hospital Care Examinations

Apheresis red cell exchange and transfusion therapy for management of sickle cell disease. Dr Paul Telfer

Trust Protocol for the Administration of Intravenous Methylprednisolone for Thyroid Eye Disease A Protocol. The Clinical Investigation Unit (CIU)

HbSC disease is it different and how should we manage it? David Rees Department of Paediatric Haematology, King s College Hospital, London

Provision of Red Cell Transfusion Support for Transfusion Dependent Patients

Guidelines for Shared Care Centres and Community Staff

The following equipment and supplies shall be maintained at a minimum. Agencies should consider typical or expected usage for optimal inventory

Wales Critical Care & Trauma Network (North) CITRATE GUIDELINES (Approved May 2015)

University Hospitals of Leicester NHS Trust ANAEMIA_IRON THERAPY FOR ANAEMIA OF CHRONIC KIDNEY DISEASE. RRCV CMG Nephrology Service

NOTTINGHAM CHILDREN S HOSPITAL Nursing Guideline. P07 Care and Management of Children with a Totally Implantable Venous Access Device (Portacath).

Trust Guidelines. Title: Guidelines for chest drain insertion

St George Hospital Renal Department Internal Policy

Management of the patient with established AKI. Kelly Wright Lead Nurse for AKI King s College Hospital

National Institute for Health and Care Excellence Medical Technologies Evaluation Programme

KINGSTON GENERAL HOSPITAL NURSING POLICY AND PROCEDURE

Intravenous therapy and medication. ELCT Health Department Quality Assurance 2007

Central Venous Line Insertion

Transcription:

Clinical guideline: manual red cell exchange in patients with sickle cell disease HN-504b Introduction Most patients with sickle cell anaemia are relatively asymptomatic despite baseline Hb concentrations between 50 120g/l as HbS is a low affinity haemoglobin and oxygen delivery to tissues is enhanced. Chronic steady state anaemia alone is not an indication for transfusion. Top up transfusion increases whole blood viscosity and may aggravate sickling. Top up transfusion is not indicated for uncomplicated sickle crises (see separate guideline on perioperative management). Exchange transfusion is a potentially life saving procedure that allows correction of anaemia without increasing blood viscosity and may improve tissue oxygenation whilst reducing microvascular sickling. The aim of exchange transfusion is to lower the HbS level to 30% or less while keeping the Haemoglobin close to 100g/l. Clinical benefit may be seen even with a partial manual exchange. Prior to embarking on an exchange procedure the case must be discussed with the Consultant Haematologist on call. Indications for manual red cell exchange transfusions NB Manual exchange is likely only to be used in the acute setting where an automated service is unavailable. Note that the NBS provides a 24 hour service for automated exchange automated exchange is always preferable. Indications for exchange include: Acute stroke Acute chest syndrome Severe sepsis Acute hepatic or splenic sequestration Multi-organ failure Progressive intrahepatic cholestasis Background This procedure should only be performed by suitably qualified staff under the supervision of the responsible Consultant Haematologist. Staff should be familiar with the procedure and management of associated complications. Version 1.2 Page 1 of 5 Manual exchange in SCD

Adult patients may require insertion of a femoral or internal jugular line but those with good peripheral access can be managed with one or preferably two large bore IV cannulae. Trust policies for safe blood transfusion must be adhered to at all times. All patients with haemoglobin disorders should receive only blood that has been subject to extended phenotyping: Blood Bank should be alerted that the patient has sickle cell disease prior to cross-matching. Pre-procedure Consent Ensure the patient has given consent for the exchange procedure. Often verbal consent alone will be practical when the patient is seriously ill. Aspects that should be specifically mentioned include: Access (peripheral vs vascath) Vasovagal episodes Blood transfusion reactions and alloimmunisation Transfusion-related infection Baseline Blood tests HbS percentage Urea and electrolytes Calcium Magnesium Liver function tests Virology HIV, hepatitis B and C Ferritin levels, glucose, thyroid and endocrine function if appropriate (not relevant in emergency setting) Inform Transfusion Laboratory of planned exchange and check for history of previous transfusion reactions or allo antibodies. The transfusion laboratory should be made aware of degree of urgency of exchange. Cross match 6 8 units of packed red cells (depending on size of patient). These should be: Sickle negative Phenotypically matched (Rh and Kell as minimum), Ideally less than 5 days old (not essential in an emergency) NB patients should have full red cell phenotype performed if this is not already known and the patient has not had recent transfusion N.B. It may be several hours before compatible blood is available for patients with allo antibodies Version 1.2 Page 2 of 5 Manual exchange in SCD

Patient Assessment Prior to the procedure, check: Blood pressure Pulse rate Oxygen saturations Temperature Weight Equipment and supplies Baxter infusion pump Blood giving set Blood warmer 500mls normal saline (several packs) Packed red cells (amount dependant on patient s size and condition, usually 6 8 units) Dynamap and tympanic thermometer Recent blood results including; haemoglobin, haematocrit, and HbS percentage Calcium gluconate in case of hypocalcaemia or hyperkalaemia Equipment for Peripheral Access/Venesection Sterile gloves 16g Kimal access needle x1 18g or 20g cannula Chloraprep/skin preparation 4x10ml syringes 20mls of normal saline for flush Tegaderm dressing to secure cannula Mepore tape to secure kimal needle Gauze swabs Consent form (if applicable) Blood collection form, observation chart and nursing documentation Large sharps box Weighing scales (to assist calculation of volume venesected) 3 way tap (useful in patients with limited peripheral access) Sterile bungs (to allow repeated access of large bore venesection pack needle into 3 way tap extension set) Venesection packs Version 1.2 Page 3 of 5 Manual exchange in SCD

Patients requiring a central line Follow local line insertion protocol Method Perform the venepuncture for the access (venesection) line and return lines. Ensure access on both sides is secured and both lines are flushed with normal saline prior to commencing the procedure. Set up the giving set for the return line so that fluid/blood administered is warmed in the blood warmer. Do not start until compatible blood is available on the ward 1. Set up a bag of normal saline and run 500mls over 15 to 30 minutes to ensure the patient is adequately pre hydrated (reduce rate/and or volume if concern over fluid overload or cardiovascular compromise). 2. Ensure the blood is warmed prior to infusing. 3. To venesect: remove 450 500mls of blood over 15 30minutes. 4. Ensure local transfusion policies are adhered to and documentation completed. 5. Calculate the amount to be exchanged, dependent on the starting haemoglobin, as follows: Hb >80g/l 5 8 units Hb 60 7.g/l 4 6 units Hb <60g/l up to 4 units Exchange Procedure if starting Hb >80g/dl Venesect 1st unit whilst Replacing with 500mls normal saline stat Venesect 2 nd unit then Transfuse 1st unit over 30 40 minutes Venesect 3rd unit then Transfuse 2nd unit over 1 hour Venesect 4th unit then Transfuse 3rd unit over 2 hours Re check FBC, HbS and electrolytes at this stage If repeat Hb<90g/l Transfuse 4th unit and consider 5th unit (3hrs each) If repeat Hb>90g/l Restart from venesect 1st unit N.B. By removing two units of blood before transfusing the 1st unit, this method results in more efficient lowering of the HbS %. However if the patient is cardiovascularly unstable, or becomes hypotensive during the venesection, the replacement transfusion should be started sooner, i.e. after venesection of the 1st unit. If starting Hb 60 79g/l Version 1.2 Page 4 of 5 Manual exchange in SCD

Venesect 1st unit whilst Transfusing 1st unit Venesect 2 nd unit then Transfuse 2nd unit over 1hr and 3rd and 4th units over 3hrs Further exchange may be required (see Hb 80g/l ) if insufficient clinical improvement/impact on HbS level If starting Hb<60g/l Top up transfusion to 80 100g/l (rate depending on clinical condition and baseline Hb) initially, discuss with Consultant Haematologist. Formal exchange may be required (see Hb 80g/l ) if insufficient clinical improvement/impact on HbS% Post procedure Remove Kimal needle but leave cannula in, flush with normal saline. Monitor vital signs at 15 and 30 minutes post procedure Take bloods 30 minutes post procedure for: o Full blood count o HbS percentage o Electrolytes, calcium and magnesium Avoid final Hb of >110g/l (risk of hyperviscosity) or <70g/l Watch for development of hyperkalaemia and hypocalcaemia during the exchange. Ensure all transfusion documentation is completed correctly and returned to blood transfusion as per local policy. Documentation and acknowledgements: Manchester Royal Infirmary, University College Hospital London, and South Thames Sickle Cell and Thalassaemia Network for allowing reference and adaptation of their guidelines for the management of Adults with Sickle Cell Disease and Thalassaemia Draft expert panel report on the management of Sickle Cell Disease, NHLBI, Bethesda, Maryland, USA, August 3 2012 Standards for the Clinical Care of Adults with Sickle Cell Disease in the UK Sickle Cell Society 2008 Authors: Dr Wale Atoyebi, Clinical Lead for Haemoglobinopathies Review Name Revision Date Version Review date Wale Atoyebi Pre-peer review Jan 2013 1.0 Jan 2015 Deborah Hay Routine review Aug 2015 1.2 Jan 2017 Version 1.2 Page 5 of 5 Manual exchange in SCD